Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127156462 | 12715646 | 2 | F | 20160906 | 20160906 | 20160912 | EXP | EC-ROCHE-1803448 | ROCHE | 0.00 | M | Y | 0.00000 | 20160912 | CN | EC | EC |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127156462 | 12715646 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | VIAL?LAST DOSE OF RITUXIMAB WAS RECEIVED ON 04/JUL/2016. | N | 103705 | 650 | MG | SOLUTION FOR INFUSION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127156462 | 12715646 | 1 | Non-Hodgkin's lymphoma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127156462 | 12715646 | Cardiac disorder | |
| 127156462 | 12715646 | Chest pain | |
| 127156462 | 12715646 | Hyperhidrosis | |
| 127156462 | 12715646 | Pain | |
| 127156462 | 12715646 | Pyrexia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127156462 | 12715646 | 1 | 20160302 | 0 |